Coronavirus Update: Sinovac Latest To Report Vaccine Success In Humans
Plus News From AZ, Sanofi, Lilly, Junshi And Merck & Co.
Sinovac's candidate is a more conventional inactivated vaccine, but is keeping pace with more modern approaches taken by Moderna and CanSino.
You may also be interested in...
Coronavirus Update: Lilly Initiates 2,400-Patient Nursing Home Trial
Dozens of specially outfitted RVs will roll out to long-term care facilities in the US to test the prophylactic and symptom-reducing potential of the antibody Lilly is developing with AbCellera.
Coronavirus Update: Regeneron Races Into Phase III Trial Of Antibodies To Block Coronavirus Infection
Regeneron and NIAID kick off a Phase III prevention trial for antibody cocktail REGN-COV2.
Coronavirus Update: How Should Remdesivir Be Priced? ICER Are In Two Minds
Independent drug cost watchdog updates its twin pricing estimates for Gilead's drug - but dexamethasone could tip the balance again.